Randomized Trial to Test the "Coordinated Care for Health Promotion and Activities in Parkinson's Disease" Intervention in the VA

Not Applicable

Completed

• Conditions: Parkinson Disease
• Interventions: Other: Coordinated care management for Parkinson's disease; Other: Educational handout

• Registration Number: NCT01532986
• Lead Sponsor: VA Office of Research and Development

Brief Summary

Health care benefits and services are received through the Veterans Health Administration (VHA), a component of the United States Department of Veterans Affairs. Over 40,000 Veterans across the Veterans Health Administration are diagnosed with Parkinson's disease (PD), a chronic condition that affects motor function as well as cognition, mood, sleep, and autonomic function. There are not enough subspecialists to manage every Veteran with Parkinson's disease. However, a care model of nurse care managers as catalysts and advocates using needs assessments, evidence-based protocols, and VHA and community access coordination mechanisms to optimize Parkinson's disease care may improve quality of Parkinson's disease care and patient-centered outcomes. If efficacious, this model may be practical to disseminate via an existing VHA national consortium network for Parkinson's disease.

Objectives are (1) to implement then analyze via a randomized controlled trial whether a nurse-led, coordinated care management intervention, Care Coordination for Health Promotion and Activities in Parkinson's Disease (CHAPS), compared to usual care will improve adherence to evidence-based practice guidelines and improve health outcomes in Veterans with Parkinson's disease in a region of the southwest United States, and (2) to analyze extent of implementation of the CHAPS intervention and its costs to determine how the intervention can be made sustainable and disseminated throughout Veterans Affairs Medical Centers if efficacious.

Detailed Description

In a 5-year randomized controlled trial, we enrolled 345 Veterans with PD that were then randomized in a 1:1 ratio to receive up to 24 months of a PD care management program, "Care Coordination for Health Promotion and Activities in Parkinson's Disease" (CHAPS), or continue with usual care. Eligible participants across 5 sites of the Southwest Parkinson's Disease Research, Education and Clinical Center (SW PADRECC): Greater Los Angeles, Las Vegas, Loma Linda, Long Beach and San Diego VISN 22 (VA Desert Pacific Healthcare Network) facilities were identified through administrative data and vetted by physicians. The multi-faceted nurse-led intervention, CHAPS, incorporated PD quality improvement (QI) tools to enhance proactive Veteran-centered care delivery. PDQI tools included: (1) a structured telephone assessment administered by a nurse care manager (NCM) to proactively identify medical problems and unmet needs; (2) problem-specific evidence-based interventions organized into treatment plans including follow-up/monitoring protocols with VA and community linkages; (3) the Siebens Domain Management ModelTM, a structural approach to improve collection and organization of health information and enrich communication among providers; (4) Siebens Health Care Notebooks prepared with Veteran self-management materials; (5) a Microsoft Access care management database, containing the CHAPS Assessment and algorithms for problem identification based on Veteran data; and (6) decision-support meetings of NCMs with movement disorder specialists. Research interviewers administer a structured telephone survey at baseline, 6, 12, 18, and 24 months. Participants were provided $25 per survey. Medical records were abstracted.

Ongoing analyses (1) measure PD quality indicator adherence, health outcomes, and health service utilization; (2) evaluate qualitative and quantitative data to summarize the extent of intervention implementation and barriers and facilitators to potential dissemination; and (3) examine costs of CHAPS care and cost offset between randomization arms to provide new knowledge to aid in future dissemination of the CHAPS Program in a "National Rollout" according to the VA Quality Enhancement Research Initiative QUERI process.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2012-01-13
• Study First Submitted QC: 2012-02-10
• Study First Posted: 2012-02-15
• Study Start: 2012-07-09
• Primary Completion: 2017-01-31
• Study Completion: 2017-04-30
• Results First Submitted: 2018-03-16
• Status Verified: 2019-03
• Results First Submitted QC: 2019-03-07
• Last Update Submitted: 2019-03-07
• Results First Posted: 2019-03-08
• Last Update Posted: 2019-03-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 345

Inclusion Criteria

• Veteran of the United States of America
• Receiving health care at one of five Veterans Health Administration medical centers in the southwest United States: Greater Los Angeles, Loma Linda, Long Beach, or San Diego, California, or Las Vegas, Nevada.
• Diagnosis of Parkinson's disease (PD)
• At least two ICD-9 diagnostic codes for PD (332.0) in the administrative data from October 1, 2010 - to present date or until recruitment target is met
• At least 18 years of age
• Must demonstrate capacity to provide consent for study participation.

Read More

Exclusion Criteria

• Any Veteran who is a study subject in the Deep Brain Stimulation (DBS) VA cooperative study as these subjects are not to enroll in any other study per DBS study protocol.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Usual Care (Arm 1)	Coordinated care management for Parkinson's disease	Veterans randomized to the usual care arm will continue to receive care they would have received if they had not enrolled in the study; no care or resources that are made available in general by VA will be withheld from participants in either arm or to any Veterans who wish to use those resources. Educational handout: brief educational handout on Parkinson's disease that is available in the VA's "Healthwise for Life" handbook.
Usual Care (Arm 1)	Educational handout	Veterans randomized to the usual care arm will continue to receive care they would have received if they had not enrolled in the study; no care or resources that are made available in general by VA will be withheld from participants in either arm or to any Veterans who wish to use those resources. Educational handout: brief educational handout on Parkinson's disease that is available in the VA's "Healthwise for Life" handbook.
Intervention (Arm 2)	Coordinated care management for Parkinson's disease	A delivery system redesign, with nurse care managers, using standardized assessment tools and care coordination protocols to address unmet needs of Veterans with Parkinson's Disease (PD) by collaborating with these Veterans and their families, providers, and community partners. Educational handout: brief educational handout on Parkinson's disease that is available in the VA's "Healthwise for Life" handbook.

Primary Outcome Measures

Name	Time	Method
Proportion of Measures Adhered To in the PD Guidelines	18 months	Adherence to quality measures for Parkinson's disease care during study period. We operationalized 18 quality measures: 12 were determined through chart review, and 6 were measured using patient survey data.; Range and direction of score: 0 (worst) to 1 (best)

Secondary Outcome Measures

Name	Time	Method
Medical Outcomes Study (MOS)	18 months	Data collected at baseline, 6, 12, 18 months. Missing values imputed by last-value carried forward.; Reported results compared compared data of baseline and final survey results. Additional analyses included repeated-measures models that included data from all time points.; Range and direction of score: 1 (worst) to 5 (best)
Percentage With a Patient Healthcare Questionnaire-2 (PHQ-2) Score ≥ 3	18 months	Data collected at baseline, 6, 12, 18 months. Missing values imputed by last-value carried forward.; PHQ-2 score ranges from 0 to 4. Reported results compared compared data of baseline and final survey results. Additional analyses included repeated-measures models that included data from all time points.; Higher scores indicate detection of depressive symptoms
Health Utilities Index (HUI3)	18 months	Data collected at baseline, 6, 12, 18 months. Missing values imputed by last-value carried forward.; Reported results compared compared data of baseline and final survey results. Additional analyses included repeated-measures models that included data from all time points.; Range and direction of score: -0.36 (worst) to 1 (best)
Activities of Daily Living (ADL), (Speech and Swallowing Only)	18 months	Data collected at baseline, 6, 12, 18 months. Missing values imputed by last-value carried forward.; Reported results compared compared data of baseline and final survey results. Additional analyses included repeated-measures models that included data from all time points.; Range and direction of score: 0 (best) to 16 (worst)
General Self-Efficacy Scale (GSES)	18 months	Data collected at baseline, 6, 12, 18 months. Missing values imputed by last-value carried forward.; Reported results compared compared data of baseline and final survey results. Additional analyses included repeated-measures models that included data from all time points.; Range and direction of score: 10 (worst) to 40 (best)
Consumer Assessment of Healthcare Providers and Systems (CAHPS)	18 months	Data collected at baseline, 6, 12, 18 months. Missing values imputed by last-value carried forward.; Reported results compared compared data of baseline and final survey results. Additional analyses included repeated-measures models that included data from all time points.; Range and direction of score: 0 (worst) to 100 (best)
Patient Assessement of Care for Chronic Conditions (PACIC)	18 months	Data collected at baseline, 6, 12, 18 months. Missing values imputed by last-value carried forward.; Reported results compared compared data of baseline and final survey results. Additional analyses included repeated-measures models that included data from all time points.; Range and direction of score: 1 (worst) to 5 (best)
World Health Organization Well-Being Index (WHO-5)	18 months	Data collected at baseline, 6, 12, 18 months. Missing values imputed by last-value carried forward.; Reported results compared compared data of baseline and final survey results. Additional analyses included repeated-measures models that included data from all time points.; Range and direction of score: 1 (worst) to 25 (best)
Patient Healthcare Questionnaire-9 (PHQ-9)	18 months	Data collected at baseline, 6, 12, 18 months. Missing values imputed by last-value carried forward.; Range and direction of score: 0 (best) to 27 (worst). Reported results compared compared data of baseline and final survey results. Additional analyses included repeated-measures models that included data from all time points.; PHQ-9 was only administered to subjects who had a score of 3 or higher on the PHQ-2

Trial Locations

Locations (5)

VA Long Beach Healthcare System, Long Beach, CA; 🇺🇸 Long Beach, California, United States

VA San Diego Healthcare System, San Diego, CA; 🇺🇸 San Diego, California, United States

VA Greater Los Angeles Healthcare System, West Los Angeles, CA; 🇺🇸 West Los Angeles, California, United States

VA Southern Nevada Healthcare System, North Las Vegas, NV; 🇺🇸 Las Vegas, Nevada, United States

VA Loma Linda Healthcare System, Loma Linda, CA; 🇺🇸 Loma Linda, California, United States